DWP-05195 clinical trials
Also written DWP05195.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses DWP-05195 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- DWP05195
- 3
Studies by the year they started
3 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses DWP-05195 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic NeuralgiaCompletedPhase 2Daewoong Pharmaceutical Co. LTD.NCT01557010Written as DWP05195
- A Multiple Dose Study of DWP05195 in Healthy Adult SubjectsCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT01094834Written as DWP05195
- DWP05195 in Healthy Adult Male VolunteersCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT00969787Written as DWP05195